PBH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PBH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Prestige Consumer Healthcare's selling, general, & admin. expense for the three months ended in Dec. 2023 was $65 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Dec. 2023 was $254 Mil.
The historical data trend for Prestige Consumer Healthcare's Selling, General, & Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Selling, General, & Admin. Expense distribution charts can be found below:
* The bar in red indicates where Prestige Consumer Healthcare's Selling, General, & Admin. Expense falls into.
Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.
Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $254 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prestige Consumer Healthcare (NYSE:PBH) Selling, General, & Admin. Expense Explanation
An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.
Warren Buffett likes companies with consistent SGA as the percentage of gross profit.
Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.
If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.
Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.
Mary Beth Fritz | officer: Senior VP Quality & Regulatory | 660 WHITE PLAINS RD, 2ND FL, TARRYTOWN NY 10591 |
Ronald M. Lombardi | officer: Chief Executive Officer | 660 WHITE PLAINS RD., TARRYTOWN NY 10591 |
James Darecca | director | C/O HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110 |
Christine Sacco | officer: Chief Financial Officer | C/O SMART BALANCE, INC., 115 WEST CENTURY ROAD, SUITE 260, PARAMUS NJ 07652 |
Adel Mekhail | other: EVP, Marketing & Sales | 660 WHITE PLAINS RD., 2ND FL, TARRYTOWN NY 10591 |
William P'pool | officer: See Remarks | 2400 WEST LLOYD EXPRESSWAY, EVANSVILLE IL 47721 |
Celeste A. Clark | director | C/O ADVANCEPIERRE FOODS HOLDINGS, INC., 9987 CARVER ROAD, BLUE ASH OH 45242 |
Christopher J Coughlin | director | |
Natale S Ricciardi | director | C/O MORRIS COMMUNICATIONS CORP, 725 BROAD ST., AUGUSTA GA 30903 |
James M Jenness | director | PO BOX 3599, BATTLECREEK MI 49016-3599 |
John E Byom | director | 660 WHITE PLAINS RD., TARRYTOWN NY 10591 |
Sheila Hopkins | director | C/O WARNACO INC, 90 PARK AVENUE, NEW YORK NY 10016 |
Dawn M. Zier | director | 600 OFFICE CENTER DRIVE, FORT WASHINGTON PA 19034 |
Jeffrey Zerillo | officer: Senior VP Operations | 660 WHITE PLAINS RD, 2ND FL, TARRYTOWN NY 10591 |
Timothy Connors | officer: Chief Marketing Officer | 660 WHITE PLAINS RD., SUITE 205, TARRYTOWN NY 10591 |
From GuruFocus
By Marketwired 07-01-2021
By sperokesalga 05-23-2023
By Marketwired 02-11-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.